NCT02162303View on ClinicalTrials.gov

Colchicine in Vascular Inflammation Assessed With PET Imaging

PHASE2CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

January 31, 2016

Conditions
Atherosclerotic Vascular Disease
Interventions
DRUG

Colchicine

0.6 mg a day of active treatment or placebo for 24 weeks

DRUG

Placebo

Sugar,given once daily, over 6 months.To mimic active treatment

Trial Locations (1)

H1T 1C8

Montreal Heart Institute, Montreal

All Listed Sponsors
lead

Montreal Heart Institute

OTHER

NCT02162303 - Colchicine in Vascular Inflammation Assessed With PET Imaging | Biotech Hunter | Biotech Hunter